Alerts will be sent to your verified email
Verify EmailKOBO
Kobo Biotech
|
MPS Pharmaa
|
Fabino Enterprises
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-1.77 % | -41.86 % | 0.76 % |
5yr average Equity Multiplier
|
4.06 | 3.24 | 2.01 |
5yr Average Asset Turnover Ratio
|
0.54 | 0.0 | 0.98 |
5yr Avg Net Profit Margin
|
-3.79 % | -5434.45 % | 0.54 % |
Price to Book
|
0.0 | 4.63 | 0.0 |
P/E
|
0.0 | 0.0 | 89.51 |
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 59.85 Days |
Inventory Days
|
89.28 Days | 1258.79 Days | 81.8 Days |
Days Receivable
|
0.0 | 0.0 | 131.05 Days |
Days Payable
|
147.48 Days | 414.72 Days | 60.4 Days |
5yr Average Interest Coverage Ratio
|
0.99 | -816.29 | 5.69 |
5yr Avg ROCE
|
11.79 % | -41.48 % | 1.29 % |
5yr Avg Operating Profit Margin
|
8.83 % | -3500.38 % | 1.24 % |
5 yr average Debt to Equity
|
1.62 | 1.97 | 0.14 |
5yr CAGR Net Profit
|
n/a | -6.64 % | -4.36 % |
5yr Average Return on Assets
|
-0.89 % | -13.25 % | 0.49 % |
Shareholdings
|
|||
Promoter Holding
|
44.95 % | 35.89 % | 56.82 % |
Share Pledged by Promoters
|
0.0 | 16.04 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Kobo Biotech
|
MPS Pharmaa
|
Fabino Enterprises
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|